Shares of LifeStance Health Group (NASDAQ: LFST) have gained 1.3% over the past four weeks to close the last trading session at $5.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.64 indicates a potential upside of 57.4%. The mean estimate comprises seven short-term price targets with a standard deviation of $0.94. While the lowest estimate of $7 indicates a 27.5% increase from the current price level, the most optimistic analyst expects the stock to surge 82.2% to reach $10. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice. However, an impressive consensus price target is not the only factor that indicates a potential upside in LFST. This view is strengthened by the agreement among analysts that the company will report ...